Status:
COMPLETED
Detection of Cytomegalovirus Virus in Neonates
Lead Sponsor:
Meridian Bioscience, Inc.
Conditions:
CMV
Eligibility:
All Genders
Up to 20 years
Brief Summary
To evaluate the illumigene CMV assay, using the illumipro-10 with neonates (up to 21 days of age) saliva swabs
Eligibility Criteria
Inclusion
- Saliva swab specimens from neonates up to 21 days of age
- Saliva swab sample placed in a nonnutritive transport medium or in a plastic sterile tube without medium.
- Flocked-nylon swabs
Exclusion
- Samples other than saliva swab from patients up to 21 days of age.
- Swabs other than flocked-nylon.
- Swabs in a viral transport media not defined in the Investigational Use Only package insert
- Multiple specimens from the same patient.
- Specimens received in the laboratory in unsatisfactory containers or condition.
Key Trial Info
Start Date :
August 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 5 2018
Estimated Enrollment :
1615 Patients enrolled
Trial Details
Trial ID
NCT03251261
Start Date
August 2 2017
End Date
March 5 2018
Last Update
January 14 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
2
University of Utah
Salt Lake City, Utah, United States, 84112
3
The Prince of Wales Hospital
Randwick, New South Wales, Australia, 2031
4
British Columbia Children's Hospital / British Columbia Women's Hospital
Vancouver, British Coloumbia, Canada, V6H 3N1